Christopher Gibson - 01 Feb 2023 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Signature
/s/ Nathan Hatfield, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
01 Feb 2023
Net transactions value
-$205,377
Form type
4
Filing time
03 Feb 2023, 16:11:41 UTC
Previous filing
28 Apr 2023
Next filing
17 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +406,800 +77% $0.000000 932,605 01 Feb 2023 Direct F1
transaction RXRX Class A Common Stock Award $0 +11,050 +1.2% $0.000000 943,655 01 Feb 2023 Direct F2
transaction RXRX Class A Common Stock Tax liability $11,816 -1,382 -0.15% $8.55 942,273 01 Feb 2023 Direct F3
transaction RXRX Class A Common Stock Conversion of derivative security $0 +18,500 +2% $0.000000 960,773 02 Feb 2023 Direct F4, F5
transaction RXRX Class A Common Stock Sale $170,548 -18,500 -1.9% $9.22 942,273 02 Feb 2023 Direct F4, F6
transaction RXRX Class A Common Stock Conversion of derivative security $0 +500 $0.000000 500 02 Feb 2023 by LAHWRAN-3 LLC F4, F5, F7
transaction RXRX Class A Common Stock Sale $4,604 -500 -100% $9.21 0 02 Feb 2023 by LAHWRAN-3 LLC F4, F7, F8
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1,000 $0.000000 1,000 02 Feb 2023 by LAHWRAN-4 LLC F4, F5, F9
transaction RXRX Class A Common Stock Sale $9,208 -1,000 -100% $9.21 0 02 Feb 2023 by LAHWRAN-4 LLC F4, F9, F10
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1,000 $0.000000 1,000 02 Feb 2023 by Gibson Family Trust F4, F5, F11
transaction RXRX Class A Common Stock Sale $9,202 -1,000 -100% $9.20 0 02 Feb 2023 by Gibson Family Trust F4, F11, F12

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Award $0 +813,600 $0.000000 813,600 01 Feb 2023 Class A Common Stock 813,600 $8.55 Direct F13
transaction RXRX Class B Common Stock Conversion of derivative security $0 -18,500 -0.28% $0.000000 6,640,334 02 Feb 2023 Class A Common Stock 18,500 $0.000000 Direct F4, F5, F16
transaction RXRX Class B Common Stock Conversion of derivative security $0 -500 -0.09% $0.000000 539,500 02 Feb 2023 Class A Common Stock 500 $0.000000 by LAHWRAN-3 LLC F4, F5, F7, F16
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1,000 -0.19% $0.000000 529,000 02 Feb 2023 Class A Common Stock 1,000 $0.000000 by LAHWRAN-4 LLC F4, F5, F9, F16
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1,000 -0.79% $0.000000 125,875 02 Feb 2023 Class A Common Stock 1,000 $0.000000 by Gibson Family Trust F4, F5, F11, F16
holding RXRX Stock Option (Right to Buy) 5,436 01 Feb 2023 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 416,350 01 Feb 2023 Class A Common Stock 0 $11.40 Direct F14
holding RXRX Stock Option (Right to Buy) 781,250 01 Feb 2023 Class A Common Stock 0 $2.48 Direct F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2023 and every three months thereafter.
F2 This RSU vested immediately upon the grant date.
F3 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
F4 Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F5 Represents the conversion of Class B Common Stock into Class A Common Stock.
F6 This transaction was executed in multiple trades at prices ranging from $8.63 to $9.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F8 This transaction was executed in multiple trades at prices ranging from $8.63 to $9.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F10 This transaction was executed in multiple trades at prices ranging from $8.66 to $9.52 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F11 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
F12 This transaction was executed in multiple trades at prices ranging from $8.64 to $9.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F13 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F14 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F15 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F16 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.